Importantly, the methylation levels of these CpG regions were both obviously decreased after demethylation treatments, indicating that low pGSN expression in ESCC is in part attributed to promoter hypermethylation of the GSN gene. The gene discussed is GSN; the disease is esophageal squamous cell carcinoma.